Newcastle disease virus (NDV) is a major threat to the poultry industry worldwide, with a diversity of genotypes associated with severe economic losses in all poultry sectors. Class II genotype VII NDV are predominant in the Middle East and Asia, despite intensive vaccination programs using conventional live and inactivated NDV vaccines. In Egypt, the disease is continuously spreading, causing severe economical losses in the poultry industry. In this study; the protective efficacy of a commercial, inactivated recombinant genotype VII NDV–matched vaccine (KBNP-C4152R2L strain) against challenge with the velogenic NDV strain (Chicken/USC/Egypt/2015) was evaluated in commercial layers. Two vaccination regimes were used; live NDV genotype II (LaSota) vaccine on days 10, 18, and 120, with either the inactivated NDV genotype II regime or inactivated NDV genotype VII–matched vaccine regime on days 14, 42, and 120. The 2 regimes were challenged at the peak of egg production on week 26. Protection by the 2 regimes was evaluated after experimental infection, based on mortality rate, clinical signs, gross lesions, virus shedding, seroconversion, and egg production schedule. The results show that these 2 vaccination regimes protected commercial layer chickens against mortality, but some birds showed mild clinical signs and reduced egg production temporarily. However, the combination of live NDV genotype II and recombinant inactivated genotype VII vaccines provided better protection against virus shedding (20% and 0% vs. 60% and 40%) as assessed in tracheal swabs and (20% and 0% vs. 20% and 20%) in cloacal swabs collected at 3 and 5 D post challenge (dpc), respectively. In addition, egg production levels in birds receiving the inactivated NDV genotype VII–matched vaccine regime and in those given inactivated genotype II vaccines were 76.6, 79, 82, and 87.4% and 77.7, 72.5, 69, and 82.5% at 7, 14, 21, and 28 dpc, respectively. The results of this study indicate that recombinant genotype-matched inactivated vaccine along with a live attenuated vaccine can reduce virus shedding and improve egg production in commercial layers challenged with a velogenic genotype VII virus under field conditions. This regime may ensure a proper control strategy in layers.
Key words: Newcastle disease virus, genotype-matched vaccine, genotype VII, layer.
Absalon, A. E., D. V. Cortes-Espinosa, E. Lucio, P. J. Miller, and C. L. Afonso. 2019. Epidemiology, control, and prevention of Newcastle disease in endemic regions: Latin America. Trop. Anim. Health Prod. 51:1033–1048.
Al-Garib, S. O., A. L. J. Gielkens, E. Gruys, and G. Kochi. 2007. Review of Newcastle disease virus with particular references to immunity and vaccination. Worlds Poult. Sci. J. 59:185–200.
Al-Habeeb, M. A., M. Mohamed, and S. Sharawi. 2013. Detection and characterization of Newcastle disease virus in clinical samples using real time RT-PCR and melting curve analysis based on matrix and fusion genes amplification. World 6:239–243.
Aldous, E. W., J. K. Mynn, R. M. Irvine, D. J. Alexander, and I. H. Brown. 2010. A molecular epidemiological investigation of avian paramyxovirus type 1 viruses isolated from game birds of the order Galliformes. Avian Pathol. 39:519–524.
Ayoub, M. A., W. Elfeil, D. E. Boraey, H. Hammam, and M. A. Nossair. 2019. Evaluation of some vaccination programs in protection of experimentally challenged broiler chicken against Newcastle disease virus. Am. J. Anim. Vet. Sci. 14.
Bogoyavlenskiy, A., V. Berezin, A. Prilipov, E. Usachev, I. Korotetskiy, I. Zaitceva, A. Kydyrmanov, and M. Sayatov. 2012. Characterization of pigeon paramyxoviruses (Newcastle disease virus) isolated in Kazakhstan in 2005. Virol. Sin. 27:93–99.
Bwala, D., F. Fasina, A. Van Wyk, and N. Duncan. 2011. Effects of vaccination with Lentogenic vaccine and challenge with virulent Newcastle disease virus (NDV) on egg production in commercial and SPF chickens. Int. J. Poult. Sci. 10:98–105.
Callison, S. A., D. A. Hilt, T. O. Boynton, B. F. Sample, R. Robison, D. E. Swayne, and M. W. Jackwood. 2006. Development and evaluation of a real-time Taqman RT-PCR assay for the detection of infectious bronchitis virus from infected chickens. J. Virol. Methods 138:60–65.
Cardenas-Garcia, S., D. G. Diel, L. Susta, E. Lucio-Decanini, Q. Yu, C. C. Brown, P. J. Miller, and C. L. Afonso. 2015. Development of an improved vaccine evaluation protocol to compare the efficacy of Newcastle disease vaccines. Biologicals 43:136–145.
Cattoli, G., L. Susta, C. Terregino, and C. Brown. 2011. Newcastle disease: a review of field recognition and current methods of labo-ratory detection. J. Vet. Diagn. Invest. 23:637–656.
Cho, S.-H., S.-J. Kim, and H.-J. Kwon. 2007. Genomic sequence of an antigenic variant Newcastle disease virus isolated in Korea. Virus Genes 35:293–302.
Cho, S.-H., H.-J. Kwon, T.-E. Kim, J.-H. Kim, H.-S. Yoo, M.-H. Park, Y.-H. Park, and S.-J. Kim. 2008. Characterization of a recombi-nant Newcastle disease virus vaccine strain. Clin. Vaccine Immu-nol. 15:1572–1579.
Diel, D. G., L. Susta, S. C. Garcia, M. L. Killian, C. C. Brown, P. J. Miller, and C. L. Afonso. 2012. Complete genome and clini-copathological characterization of a virulent Newcastle disease virus isolate from South America. J. Clin. Microbiol. 50:378–387.
Dimitrov, K. M., C. L. Afonso, Q. Yu, and P. J. Miller. 2017. New-castle disease vaccines-a solved problem or a continuous challenge? Vet. Microbiol. 206:126–136.
Dortmans, J. C., B. P. Peeters, and G. Koch. 2012. Newcastle disease virus outbreaks: vaccine mismatch or inadequate application? Vet. Microbiol. 160:17–22.
Ecco, R., L. Susta, C. L. Afonso, P. J. Miller, and C. Brown. 2011. Neurological lesions in chickens experimentally infected with virulent Newcastle disease virus isolates. Avian Pathol. 40:145–152.
El Naggar, R. F., M. A. Rohaim, A. H. Bazid, K. A. Ahmed, H. A. Hussein, and M. Munir. 2018. Biological characterization of wild-bird-origin avian avulavirus 1 and efficacy of currently applied vaccines against potential infection in commercial poultry. Arch. Virol. 163:2743–2755.
Hassan, S. 2018. Current Situation of Newcastle Disease and Efficacy of Commercaially Avialable Vaccines against Genotype VII. Sadat City University, Egypt. PhD.
Jeon, W.-J., E.-K. Lee, Y.-J. Lee, O.-M. Jeong, Y.-J. Kim, J.-H. Kwon, and K.-S. Choi. 2008. Protective efficacy of commercial inactivated Newcastle disease virus vaccines in chickens against a recent Korean epizootic strain. J. Vet. Sci. 9:295–300.
Ji, Y., T. Liu, Y. Du, X. Cui, Q. Yu, Z. Wang, J. Zhang, Y. Li, and Q. Zhu. 2018. A novel genotype VII Newcastle disease virus vaccine candidate generated by mutation in the L and F genes confers improved protection in chickens. Vet. Microbiol. 216:99–106.
Kapczynski, D. R., C. L. Afonso, and P. J. Miller. 2013. Immune re-sponses of poultry to Newcastle disease virus. Dev. Comp. Immu-nol. 41:447–453.
Khan, T. A., C. A. Rue, S. F. Rehmani, A. Ahmed, J. L. Wasilenko, P. J. Miller, and C. L. Afonso. 2010. Phylogenetic and biological characterization of Newcastle disease virus isolates from Pakistan. J. Clin. Microbiol. 48:1892–1894.
Kim, S. H., and S. K. Samal. 2017. Heterologous prime-boost immu-nization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses. Vaccine 35:4133–4139.
Kristeen-Teo, Y. W., S. K. Yeap, S. W. Tan, A. R. Omar, A. Ideris, S. G. Tan, and N. B. Alitheen. 2017. The effects of different velo-genic NDV infections on the chicken bursa of Fabricius. BMC Vet. Res. 13:151.
Li, R., K. Guo, C. Liu, J. Wang, D. Tan, X. Han, C. Tang, Y. Zhang, and J. Wang. 2016. Strong inflammatory responses and apoptosis in the oviducts of egg-laying hens caused by genotype VIId New-castle disease virus. BMC Vet. Res. 12:255.
Li, R., X. Qi, X. Han, C. Liu, J. Wang, R. Wang, J. Wang, and J. Huang. 2017. Deterioration of eggshell quality is related to cal-bindin in laying hens infected with velogenic genotype VIId New-castle disease virus. Theriogenology 91:62–68.
Liu, M., Y. Qu, F. Wang, S. Liu, and H. Sun. 2015. Genotypic and pathotypic characterization of Newcastle disease virus isolated from racing pigeons in China. Poult. Sci. 94:1476–1482.
Liu, J., J. Zhu, H. Xu, J. Li, Z. Hu, S. Hu, X. W. And, and X. Liu. 2017. Effects of the HN antigenic difference between the vaccine strain and the challenge strain of Newcastle disease virus on virus shed-ding and transmission. Viruses 9. https://doi.org/10.3390/ v9080225.
Miller, P. J., D. J. King, C. L. Afonso, and D. L. Suarez. 2007. Anti-genic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge. Vaccine 25:7238–7246.
Miller, P. J., C. Estevez, Q. Yu, D. L. Suarez, and D. J. King. 2009. Comparison of viral shedding following vaccination with inacti-vated and live Newcastle disease vaccines formulated with wild-type and recombinant viruses. Avian Dis. 53:39–49.
Miller, P. J., C. L. Afonso, J. El Attrache, K. M. Dorsey, S. C. Courtney, Z. Guo, and D. R. Kapczynski. 2013. Effects of Newcastle disease virus vaccine antibodies on the shedding and transmission of challenge viruses. Dev. Comp. Immunol. 41:505– 513.
Mohamed, M. H., A. M. Abdelaziz, S. Kumar, M. A. Al-Habib, and M. M. Megahed. 2016. Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homolo-gous and heterologous DNA vaccination in chickens. Avian Pathol. 45:228–234.
Monne, I., S. Ormelli, A. Salviato, C. De Battisti, F. Bettini, A. Salomoni, A. Drago, B. Zecchin, I. Capua, and G. Cattoli. 2008. Development and validation of a one-step real-time PCR assay for simultaneous detection of subtype H5, H7, and H9 avian influenza viruses. J. Clin. Microbiol. 46:1769–1773.
Nakamura, K., M. Ito, T. Nakamura, Y. Yamamoto, M. Yamada, M. Mase, and K. Imai. 2014. Pathogenesis of Newcastle disease in vaccinated chickens: pathogenicity of isolated virus and vaccine effect on challenge of its virus. J. Vet. Med. Sci. 76:31–36.
Nolan, T., R. E. Hands, and S. A. Bustin. 2006. Quantification of mRNA using real-time RT-PCR. Nat. Protoc. 1:1559.
OIE 2012. Newcastle Disease in OIE Manual of Standers for Diagnosis Test and Vaccines. OIE, France, 2012.
Palya, V., T. Tatar-Kis, T. Mato, B. Felf€oldi, E. Kovacs, and Y. Gardin. 2014. Onset and long-term duration of immunity pro-vided by a single vaccination with a turkey herpesvirus vector ND vaccine in commercial layers. Vet. Immunol. Immunopathol. 158:105–115.
Pandarangga, P., C. C. Brown, P. J. Miller, R. Haddas, S. F. Rehmani, C. L. Afonso, and L. Susta. 2016. Pathogenesis of new strains of Newcastle disease virus from Israel and Pakistan. Vet. Pathol. 53:792–796.
Qin, Z.-M., L.-T. Tan, H.-Y. Xu, B.-C. Ma, Y.-L. Wang, X.-Y. Yuan, and W.-J. Liu. 2008. Pathotypical characterization and molecular epidemiology of Newcastle disease virus isolates from different hosts in China from 1996 to 2005. J. Clin. Microbiol. 46:601–611.
Raghul, J., G. D. Raj, B. M. Manohar, and C. Balachandran. 2006. Protection of the reproductive tract of young chicks by Newcastle disease virus-induced haemagglutinationinhibition antibodies. Vet. Res. Commun. 30:95–102.
Rehmani, S. F., A. Wajid, T. Bibi, B. Nazir, N. Mukhtar, A. Hussain, N. A. Lone, T. Yaqub, and C. L. Afonso. 2015. Presence of virulent Newcastle disease virus in vaccinated chickens in farms in Pakistan. J. Clin. Microbiol. 53:1715–1718.
Samad, M., M. Kafi, M. Amin, and M. Gani. 2007. Investigation on the immunity level of breeder flocks following vaccination with New-castle disease virus vaccine. Bangl. J. Vet. Med. 5:15–18.
Sedeik, M. E., A. R. Elbestawy, N. A. El-shall, M. E. Abd El-Hack, I. M. Saadeldin, and A. A. Swelum. 2018. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens. Poult. Sci. 98:2000–2007.
Shahar, E., R. Haddas, D. Goldenberg, A. Lublin, I. Bloch, N. Bachner Hinenzon, and J. Pitcovski. 2018. Newcastle disease virus: is an updated attenuated vaccine needed? Avian Pathol. 47:467–478.
Shittu, I., T. M. Joannis, G. N. Odaibo, and O. D. Olaleye. 2016. Newcastle disease in Nigeria: epizootiology and current knowledge of circulating genotypes. Virus Dis. 27:329–339.
Shunlin, H., M. Huailiang, W. Yantao, L. Wenbo, W. Xiaoquan, L. Yuliang, and L. Xiufan. 2009. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse ge-netics. Vaccine 27:904–910.
Slomka, M. J., T. Pavlidis, J. Banks, W. Shell, A. McNally, and S. Essen. 2007. Validated H5 Eurasian real-time reverse tran-scriptase– polymerase chain reaction and its application in H5N1 outbreaks in 2005–2006. Avian Dis. 51:373–377.
Snoeck, C. J., A. A. Owoade, E. Couacy-Hymann, B. R. Alkali, M. P. Okwen, A. T. Adeyanju, G. F. Komoyo, E. Nakoune, A. Le Faou, and C. P. Muller. 2013. High genetic diversity of Newcastle disease virus in poultry in West and Central Africa: cocirculation of genotype XIV and newly defined genotypes XVII and XVIII. J. Clin. Microbiol. 51:2250–2260.
Steel, R. G. D., and J. H. Torrie. 1960. Principles and Procedures of Statics. Mcgraw Hill Book Comp. Inc., London.
Sultan, H. A.-E., A. M. Arafa, s. M. talaat, A. A.-E. R. Gaballa, W. H. Kilany, W. K. Elfeil, A. A. Shehata, and N. M. Amarin. 2019. Efficacy of clade 2. 3.2 H5-recombinant Baculovirus vaccine in protecting Muscovy and Pekin ducks from clade 2.3. 4.4 H5N8 highly pathogenic avian influenza infection. Avian Dis. 63.
Swayne, D. E., and J. R. Glisson. 2013. Diseases of Poultry. Wiley-Blackwell, Ames, Iowa.
van Boven, M., A. Bouma, T. H. Fabri, E. Katsma, L. Hartog, and G. Koch. 2008. Herd immunity to Newcastle disease virus in poultry by vaccination. Avian Pathol. 37:1–5.
Wang, Y., Z. Duan, S. Hu, Y. Kai, X. Wang, Q. Song, L. Zhong, Q. Sun, X. Wang, Y. Wu, and X. Liu. 2012. Lack of detection of host associated differences in Newcastle disease viruses of genotype VIId isolated from chickens and geese. Virol. J. 9:197.
Wang, Z., H. Liu, J. Xu, J. Bao, D. Zheng, C. Sun, R. Wei, C. Song, and J. Chen. 2006. Genotyping of Newcastle disease viruses iso-lated from 2002 to 2004 in China. Ann. N. Y. Acad. Sci. 1081:228– 239.
Xiao, S., A. Paldurai, B. Nayak, A. Samuel, E. E. Bharoto, T. Y. Prajitno, P. L. Collins, and S. K. Samal. 2012. Complete genome sequences of Newcastle disease virus strains circulating in chicken populations of Indonesia. J. Virol. 86:5969–5970.
Yang, H.-M., J. Zhao, J. Xue, Y.-L. Yang, and G.-Z. Zhang. 2017. Antigenic variation of LaSota and genotype VII Newcastle disease virus (NDV) and their efficacy against challenge with velogenic NDV. Vaccine 35:27–32.
Yu, L., Z. Wang, Y. Jiang, L. Chang, and J. Kwang. 2001. Charac-terization of newly emerging Newcastle disease virus isolates from the People’s Republic of China and Taiwan. J. Clin. Microbiol. 39:3512–3519.
Thank you for this valuable article, I would like to know the age for the injection. The other question is about the using of a live vaccine with the inactivated vaccine? Generally, we use a mild live vaccine wit the inactivated vaccines at the first day in our farms in Iran.
with the best,